CREBH-FGF21 axis improves hepatic steatosis by suppressing adipose tissue lipolysis. Academic Article uri icon

Overview

abstract

  • Adipose tissue lipolysis produces glycerol and nonesterified fatty acids (NEFA) that serve as energy sources during nutrient scarcity. Adipose tissue lipolysis is tightly regulated and excessive lipolysis causes hepatic steatosis, as NEFA released from adipose tissue constitutes a major source of TG in the liver of patients with nonalcoholic fatty liver diseases. Here we show that the liver-enriched transcription factor CREBH is activated by TG accumulation and induces FGF21, which suppresses adipose tissue lipolysis, ameliorating hepatic steatosis. CREBH-deficient mice developed severe hepatic steatosis due to increased adipose tissue lipolysis, when fasted or fed a high-fat low-carbohydrate ketogenic diet. FGF21 production was impaired in CREBH-deficient mice, and adenoviral overexpression of FGF21 suppressed adipose tissue lipolysis and improved hepatic steatosis in these mice. Thus, our results uncover a negative feedback loop in which CREBH regulates NEFA flux from adipose tissue to the liver via FGF21.

publication date

  • June 15, 2016

Research

keywords

  • Adipose Tissue
  • Cyclic AMP Response Element-Binding Protein
  • Fatty Liver
  • Fibroblast Growth Factors
  • Lipolysis

Identity

PubMed Central ID

  • PMC4908383

Scopus Document Identifier

  • 84974815432

Digital Object Identifier (DOI)

  • 10.1038/srep27938

PubMed ID

  • 27301791

Additional Document Info

volume

  • 6